Clinical Trial Update: Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting [Phase 2]

View source ↗

Summary

Phase 2 trial update for an improved breast cancer therapy (I-BCT-1) in neoadjuvant and metastatic settings; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Oslo University Hospital | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING